Membrane-lipid associated IncRNA: A new regulator in cancer signaling

被引:127
作者
Ma, Yanxiu [1 ]
Zhang, Junmei [1 ]
Wen, Lixia [2 ]
Lin, Aifu [1 ]
机构
[1] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China
基金
美国国家科学基金会;
关键词
Cytoplasmic IncRNA; Lipid; ceRNA; Cancer; Signaling pathway; LONG NONCODING RNA; HEPATOCELLULAR-CARCINOMA; POOR-PROGNOSIS; BREAST-CANCER; MIR-101-3P; EXPRESSION; SNHG6; AKT;
D O I
10.1016/j.canlet.2018.01.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Long noncoding RNAs (LncRNAs) are one of the emerging regulators which are involved in diverse biological processes. LncRNAs can participate in the regulation of gene expression via various ways in the cytoplasm and the nucleus. The function of the nuclear LncRNAs has been studied a lot. Recent studies have shown that the regulatory roles of cytoplasmic IncRNA, including membrane lipid associated IncRNA, which may open an unexplored mechanistic territory. LncRNA dysregulated expression represents a common event in pathogenesis of a variety of human genetic diseases including cancer. Lipid associated IncRNA is capable of modulating critical cellular functions by directly interacting with phospholipids on the plasma membrane. Besides, it also could be a predictor for the poor prognosis of cancer. In this review, we sum up the roles of cytoplasmic IncRNA, especially lipid-associated IncRNA in cancer. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:27 / 29
页数:3
相关论文
共 30 条
  • [1] [Anonymous], 2017, PATHOL ONCOL RES
  • [2] Long Noncoding RNAs From Clinical Genetics to Therapeutic Targets?
    Boon, Reinier A.
    Jae, Nicolas
    Holdt, Lesca
    Dimmeler, Stefanie
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (10) : 1214 - 1226
  • [3] Scan of human genome reveals no new loci under ancient balancing selection
    Bubb, K. L.
    Bovee, D.
    Buckley, D.
    Haugen, E.
    Kibukawa, M.
    Paddock, M.
    Palmieri, A.
    Subramanian, S.
    Zhou, Y.
    Kaul, R.
    Green, P.
    Olson, M. V.
    [J]. GENETICS, 2006, 173 (04) : 2165 - 2177
  • [4] The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma
    Cao, C.
    Zhang, T.
    Zhang, D.
    Xie, L.
    Zou, X.
    Lei, L.
    Wu, D.
    Liu, L.
    [J]. ONCOGENE, 2017, 36 (08) : 1112 - 1122
  • [5] Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma
    Chang, Lei
    Yuan, Yufeng
    Li, Cuicui
    Guo, Tao
    Qi, Haolong
    Xiao, Yusha
    Dong, Xu
    Liu, Zhisu
    Liu, Quanyan
    [J]. CANCER LETTERS, 2016, 383 (02) : 183 - 194
  • [6] EGF-ERBB signalling: towards the systems level
    Citri, Ami
    Yarden, Yosef
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (07) : 505 - 516
  • [7] Long non-coding RNAs may serve as biomarkers in breast cancer combined with primary lung cancer
    Ding, Xianfeng
    Zhang, Yuhan
    Yang, Hongjian
    Mao, Weimin
    Chen, Bo
    Yang, Shifeng
    Ding, Xiaowen
    Zou, Dehong
    Mo, Wenju
    He, Xiangming
    Zhang, Xiping
    [J]. ONCOTARGET, 2017, 8 (35) : 58210 - 58221
  • [8] Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate
    Franke, TF
    Kaplan, DR
    Cantley, LC
    Toker, A
    [J]. SCIENCE, 1997, 275 (5300) : 665 - 668
  • [9] The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer
    Huang, Weizhen
    Tian, Yunming
    Dong, Shaoting
    Cha, Yinlian
    Li, Jun
    Guo, Xiaohong
    Yuan, Xia
    [J]. ONCOLOGY REPORTS, 2017, 38 (03) : 1402 - 1410
  • [10] Visualization of membrane RNAs
    Janas, T
    Yarus, M
    [J]. RNA, 2003, 9 (11) : 1353 - 1361